| Jennifer Leigh Hoversland, APRN-FNP | |
|
301 Knapp St, Wolf Point, MT 59201-1826 | |
| (406) 653-2150 | |
| Not Available |
| Full Name | Jennifer Leigh Hoversland |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 17 Years |
| Location | 301 Knapp St, Wolf Point, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194996413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 22945 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sheridan Memorial Hosptial | Plentywood, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sheridan Memorial Hospital Association | 9133038706 | 10 |
News Archive
Speaking to the 18th International AIDS Conference today, Bill Gates called on all countries to keep up the fight against HIV/AIDS, saying the world has an historic opportunity to "change the face of AIDS." Mr. Gates said current efforts to treat people with HIV are saving millions of lives, and urged a renewed focus on reducing annual new HIV infections up to 90% by 2031, the year that will mark 50 years of the AIDS epidemic.
Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.
The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.
Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of Kyprolis® (carfilzomib) for Injection for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy.
For the first time, a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment, a memory disorder considered a strong early predictor of Alzheimer's disease, to Alzheimer's.
› Verified 8 days ago
| Entity Name | Wolf Point Clinic Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992722904 PECOS PAC ID: 3678546660 Enrollment ID: O20040817001372 |
News Archive
Speaking to the 18th International AIDS Conference today, Bill Gates called on all countries to keep up the fight against HIV/AIDS, saying the world has an historic opportunity to "change the face of AIDS." Mr. Gates said current efforts to treat people with HIV are saving millions of lives, and urged a renewed focus on reducing annual new HIV infections up to 90% by 2031, the year that will mark 50 years of the AIDS epidemic.
Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.
The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.
Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of Kyprolis® (carfilzomib) for Injection for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy.
For the first time, a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment, a memory disorder considered a strong early predictor of Alzheimer's disease, to Alzheimer's.
› Verified 8 days ago
| Entity Name | Sheridan Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891859641 PECOS PAC ID: 9133038706 Enrollment ID: O20040903000553 |
News Archive
Speaking to the 18th International AIDS Conference today, Bill Gates called on all countries to keep up the fight against HIV/AIDS, saying the world has an historic opportunity to "change the face of AIDS." Mr. Gates said current efforts to treat people with HIV are saving millions of lives, and urged a renewed focus on reducing annual new HIV infections up to 90% by 2031, the year that will mark 50 years of the AIDS epidemic.
Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.
The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.
Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of Kyprolis® (carfilzomib) for Injection for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy.
For the first time, a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment, a memory disorder considered a strong early predictor of Alzheimer's disease, to Alzheimer's.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Leigh Hoversland, APRN-FNP 7744 Road 2032, Wolf Point, MT 59201-7243 Ph: (406) 392-5310 | Jennifer Leigh Hoversland, APRN-FNP 301 Knapp St, Wolf Point, MT 59201-1826 Ph: (406) 653-2150 |
News Archive
Speaking to the 18th International AIDS Conference today, Bill Gates called on all countries to keep up the fight against HIV/AIDS, saying the world has an historic opportunity to "change the face of AIDS." Mr. Gates said current efforts to treat people with HIV are saving millions of lives, and urged a renewed focus on reducing annual new HIV infections up to 90% by 2031, the year that will mark 50 years of the AIDS epidemic.
Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.
The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.
Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of Kyprolis® (carfilzomib) for Injection for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy.
For the first time, a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment, a memory disorder considered a strong early predictor of Alzheimer's disease, to Alzheimer's.
› Verified 8 days ago
Mr. Timothy James Kurokawa, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Box 729, Wolf Point, MT 59201 Phone: 406-653-1641 Fax: 406-653-3728 | |
Mrs. Danette A Mcintyre, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 301 Knapp St, Wolf Point, MT 59201 Phone: 406-653-2150 Fax: 406-653-6591 | |
Mrs. Abby Lynn Reum, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 315 Knapp St, Wolf Point, MT 59201 Phone: 406-768-5171 | |
Ms. Barbara Anne Antonson, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 301 Knapp St, Wolf Point, MT 59201 Phone: 406-653-2150 Fax: 406-653-6591 | |
Kathy Jolene Wulf, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 315 Knapp St, Wolf Point, MT 59201 Phone: 406-653-6513 Fax: 406-653-6591 | |
Kelsey Haugo, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 301 Knapp St, Wolf Point, MT 59201 Phone: 406-653-6500 |